| Retrospective detection of asymptomatic monkeypox virus infections among male sexual health clinic attendees in Belgium I De Baetselier, C Van Dijck, C Kenyon, J Coppens, J Michiels, T de Block, ... Nature medicine 28 (11), 2288-2292, 2022 | 289 | 2022 |
| Griffithsin has antiviral activity against hepatitis C virus P Meuleman, A Albecka, S Belouzard, K Vercauteren, L Verhoye, ... Antimicrobial agents and chemotherapy 55 (11), 5159-5167, 2011 | 197 | 2011 |
| Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo EH Vakaniaki, C Kacita, E Kinganda-Lusamaki, Á O’toole, ... Nature medicine 30 (10), 2791-2795, 2024 | 178 | 2024 |
| Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody L Mailly, F Xiao, J Lupberger, GK Wilson, P Aubert, FHT Duong, ... Nature biotechnology 33 (5), 549-554, 2015 | 163 | 2015 |
| Superior in vivo transduction of human hepatocytes using engineered AAV3 capsid K Vercauteren, BE Hoffman, I Zolotukhin, GD Keeler, JW Xiao, ... Molecular Therapy 24 (6), 1042-1049, 2016 | 150 | 2016 |
| Is hepatitis E virus an emerging problem in industrialized countries? IM Sayed, AS Vercouter, SF Abdelwahab, K Vercauteren, P Meuleman Hepatology 62 (6), 1883-1892, 2015 | 131 | 2015 |
| The IFN-λ-IFN-λR1-IL-10Rβ complex reveals structural features underlying type III IFN functional plasticity JL Mendoza, WM Schneider, HH Hoffmann, K Vercauteren, KM Jude, ... Immunity 46 (3), 379-392, 2017 | 116 | 2017 |
| The Sin3a repressor complex is a master regulator of STAT transcriptional activity L Icardi, R Mori, V Gesellchen, S Eyckerman, L De Cauwer, J Verhelst, ... Proceedings of the National Academy of Sciences 109 (30), 12058-12063, 2012 | 108 | 2012 |
| Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice K Lacek, K Vercauteren, K Grzyb, M Naddeo, L Verhoye, MP Słowikowski, ... Journal of hepatology 57 (1), 17-23, 2012 | 106 | 2012 |
| Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells E Billerbeck, MC Mommersteeg, A Shlomai, JW Xiao, L Andrus, A Bhatta, ... Journal of hepatology 65 (2), 334-343, 2016 | 88 | 2016 |
| Apolipoprotein E mediates evasion from hepatitis C virus neutralizing antibodies C Fauvelle, DJ Felmlee, E Crouchet, JY Lee, L Heydmann, M Lefèvre, ... Gastroenterology 150 (1), 206-217. e4, 2016 | 83 | 2016 |
| Flunarizine prevents hepatitis C virus membrane fusion in a genotype‐dependent manner by targeting the potential fusion peptide within E1 PM Perin, S Haid, RJP Brown, J Doerrbecker, K Schulze, C Zeilinger, ... Hepatology 63 (1), 49-62, 2016 | 76 | 2016 |
| Successful anti‐scavenger receptor class B type I (SR‐BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR‐BI … K Vercauteren, N Van Den Eede, AA Mesalam, S Belouzard, ... Hepatology 60 (5), 1508-1518, 2014 | 65 | 2014 |
| Expansion, in vivo–ex vivo cycling, and genetic manipulation of primary human hepatocytes E Michailidis, K Vercauteren, L Mancio-Silva, L Andrus, C Jahan, ... Proceedings of the National Academy of Sciences 117 (3), 1678-1688, 2020 | 59 | 2020 |
| HCV animal models and liver disease K Vercauteren, YP de Jong, P Meuleman Journal of hepatology 61 (1), S26-S33, 2014 | 58 | 2014 |
| Animal models for the study of HCV K Vercauteren, YP de Jong, P Meuleman Current opinion in virology 13, 67-74, 2015 | 43 | 2015 |
| Identification of novel therapeutic targets for fibrolamellar carcinoma using patient-derived xenografts and direct-from-patient screening G Lalazar, D Requena, L Ramos-Espiritu, D Ng, PD Bhola, YP De Jong, ... Cancer discovery 11 (10), 2544-2563, 2021 | 39 | 2021 |
| Characterization of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line L Earnest-Silveira, B Chua, R Chin, D Christiansen, D Johnson, ... Journal of General Virology 97 (8), 1865-1876, 2016 | 35 | 2016 |
| Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice K Vercauteren, RJP Brown, AA Mesalam, J Doerrbecker, S Bhuju, ... Gut 65 (12), 2029-2034, 2016 | 32 | 2016 |
| Presymptomatic viral shedding in high‐risk mpox contacts: A prospective cohort study I Brosius, C Van Dijck, J Coppens, L Vandenhove, E Bangwen, F Vanroye, ... Journal of Medical Virology 95 (5), e28769, 2023 | 31 | 2023 |
